OPKO Health, Inc. (NYSE:OPK), a multi-national biopharmaceutical and diagnostics company, today reported operating and financial highlights for the third quarter of 2013.
•Cash, cash equivalents and marketable securities were $180.8 million as of September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
